June is Cancer immunotherapy month, and Clinakos Inc. nothing excites us more than getting to know about new breakthrough therapies and innovations in Oncology and Precision Medicine!
✨ In a recent study (April 2025), researchers have unveiled EchoBack-CAR T-cells—next-gen, ultrasound-controlled immune cells with game-changing benefits:
5x longer attack on tumor cells vs. standard CAR T-cells
Remotely activated by focused ultrasound for ultra-precise targeting
Fewer hospital visits—potentially just once every two weeks!
Smart safety: Deactivate outside tumors to protect healthy tissue
Feedback mechanism: Tumor cells trigger more cancer-fighting molecules
Ready for real-world use and adaptable for solid tumors like breast cancer & retinoblastoma
This innovation is a huge leap forward—bringing new hope to patients facing tough-to-treat cancers.
See the link to the original article: https://lnkd.in/gx76FNJ6
What excites you most about the future of immunotherapy and data-driven healthcare? Let’s connect and discuss!
Reach out to us at https://lnkd.in/gp3gUmXc
Follow us at Clinakos Inc.
